Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia
Data up to Jan 2025
Total Citations Per Year
Abstract
References (49)
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
1992 • 5,504 citations
A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia
1988 • 4,963 citations
Unresponsiveness to Cannabinoids and Reduced Addictive Effects of Opiates in CB 1 Receptor Knockout Mice
1999 • 3,597 citations
Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors
1995 • 2,837 citations
2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain
1995 • 2,122 citations
Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
1996 • 2,079 citations
SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
1994 • 1,743 citations
Leptin-regulated endocannabinoids are involved in maintaining food intake
2001 • 1,557 citations
Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase
2001 • 1,276 citations
Modulation of anxiety through blockade of anandamide hydrolysis
2002 • 1,251 citations
Control of pain initiation by endogenous cannabinoids
1998 • 1,044 citations
2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB 1 receptor
2001 • 752 citations
Preserved Acute Pain and Reduced Neuropathic Pain in Mice Lacking PKCγ
1997 • 685 citations
An anorexic lipid mediator regulated by feeding
2001 • 685 citations
SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor.
1998 • 679 citations
Chemical Characterization of a Family of Brain Lipids That Induce Sleep
1995 • 605 citations
Characterization of a Novel Endocannabinoid, Virodhamine, with Antagonist Activity at the CB1 Receptor
2002 • 601 citations
Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors
1998 • 496 citations
Pain modulation by release of the endogenous cannabinoid anandamide
1999 • 482 citations
Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent
1993 • 453 citations
Partial sciatic nerve injury in the mouse as a model of neuropathic pain: behavioral and neuroanatomical correlates
1998 • 432 citations
The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice.
1994 • 383 citations
The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain
2001 • 369 citations
The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain
1998 • 351 citations
N-(2-Hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation
1996 • 325 citations
The analgesic effects of R(+)-WIN 55,212–2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain
1997 • 299 citations
Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716
1996 • 287 citations
Antihyperalgesic effects of spinal cannabinoids
1998 • 282 citations
Investigation of brain sites mediating cannabinoid-induced antinociception in rats: evidence supporting periaqueductal gray involvement.
1996 • 255 citations
CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain
2002 • 233 citations
Pharmacological Activity of Fatty Acid Amides Is Regulated, but Not Mediated, by Fatty Acid Amide Hydrolase in Vivo
2002 • 223 citations
Δ9-Tetrahydrocannabinol impairs spatial memory through a cannabinoid receptor mechanism
1996 • 213 citations
Endocannabinoids and pain: spinal and peripheral analgesia in inflammation and neuropathy
2002 • 186 citations
Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat
2002 • 186 citations
Increased Seizure Susceptibility and Proconvulsant Activity of Anandamide in Mice Lacking Fatty Acid Amide Hydrolase
2003 • 183 citations
Hypoactivity of the Spinal Cannabinoid System Results in NMDA-Dependent Hyperalgesia
1998 • 176 citations
Cannabinoid analgesia
2002 • 173 citations
SR 141716A enhances spatial memory as assessed in a radial-arm maze task in rats
2000 • 169 citations
Spinal and peripheral mechanisms of cannabinoid antinociception: behavioral, neurophysiological and neuroanatomical perspectives
2002 • 160 citations
Characterization of Δ9-Tetrahydrocannabinol and Anandamide Antinociception in Nonarthritic and Arthritic Rats
1998 • 153 citations
Anti-edema and analgesic properties of delta9-tetrahydrocannabinol (THC).
1973 • 115 citations
A cannabinoid agonist differentially attenuates deep tissue hyperalgesia in animal models of cancer and inflammatory muscle pain
2003 • 112 citations
Administration of Endocannabinoids Prevents a Referred Hyperalgesia Associated with Inflammation of the Urinary Bladder
2001 • 107 citations
Two distinctive antinociceptive systems in rats with pathological pain
2000 • 104 citations
The Selective Cannabinoid Antagonist SR 141716A Blocks Cannabinoid-Induced Antinociception in Rats
1997 • 93 citations
Tonic analgesic effects of Δ9-tetrahydrocannabinol as measured with the formalin test
1980 • 50 citations
Structural requirements for cannabinoid-induced antinociceptive activity in mice
1985 • 38 citations
I. Évaluation de la douleur aiguë chez l’animal d’expérience. Première partie
2001 • 35 citations
HU-210 shows higher efficacy and potency than morphine after intrathecal administration in the mouse formalin test
2001 • 31 citations